# Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)

> **NCT02447822** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 154 (estimated)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** Thymoglobulin

## Key facts

- **NCT ID:** NCT02447822
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447822, "Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02447822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*